BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37931439)

  • 1. Fluorescence lifetime imaging microscopy for early diagnosis and severity prediction of preeclampsia with Nile Blue probe.
    Zhu Y; Wu B; Gao X; Guo Y; Peng X; Wang L; Tian X; Wang J; Yan W; Zhang H; Qu J
    Biosens Bioelectron; 2024 Jan; 244():115809. PubMed ID: 37931439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrally resolved fluorescence lifetime imaging of Nile red for measurements of intracellular polarity.
    Levitt JA; Chung PH; Suhling K
    J Biomed Opt; 2015 Sep; 20(9):096002. PubMed ID: 26334975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
    Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
    Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns.
    Portelli M; Baron B
    J Pregnancy; 2018; 2018():2632637. PubMed ID: 30050697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential early biomarkers of preeclampsia.
    Timofeeva AV; Gusar VA; Kan NE; Prozorovskaya KN; Karapetyan AO; Bayev OR; Chagovets VV; Kliver SF; Iakovishina DY; Frankevich VE; Sukhikh GT
    Placenta; 2018 Jan; 61():61-71. PubMed ID: 29277273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
    Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
    Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester preeclampsia screening and prediction.
    Chaemsaithong P; Sahota DS; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for early preeclampsia risk using maternal characteristics and estimated placental volume.
    Kim YR; Jung I; Park G; Chang SW; Cho HY
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1155-1160. PubMed ID: 31220966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
    Duan H; Zhao G; Xu B; Hu S; Li J
    Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential for diagnosis in preeclampsia].
    Marinov B; Manolov V; Vasilev V; Andonova I
    Akush Ginekol (Sofiia); 2013; 52 Suppl 2():49-55. PubMed ID: 24294763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and JMJD6 Signature in Circulating Placental Extracellular Vesicles for the Detection of Preeclampsia.
    Alahari S; Ausman J; Porter T; Park C; Pettersson ABV; Klemetti MM; Zhang J; Post M; Caniggia I
    Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36683415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.